AP NEWS

Intersect ENT to Present at the Piper Jaffray 30th Annual Healthcare Conference

November 7, 2018

MENLO PARK, Calif.--(BUSINESS WIRE)--Nov 7, 2018--Intersect ENT, Inc. (Nasdaq:XENT) today announced that management will participate in the 30 th Annual Piper Jaffray Health Care Conference on November 28 at the Lotte New York Palace in New York City, and will present in a session at 10:30am ET.

A replay of the session will be available via the investors section of the company’s website at www.intersectENT.com. The webcast replay will be archived for approximately one month.

About Intersect ENT®

Intersect ENT is dedicated to transforming ear, nose and throat care by providing innovative, clinically meaningful therapies to physicians and patients. The company’s steroid releasing implants are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. In addition, Intersect ENT is continuing to expand its portfolio of products based on the company’s unique localized steroid releasing technology and is committed to broadening patient access to less invasive and more cost-effective care.

For additional information on the company or its products, including risks and benefits, please visit www.IntersectENT.com.

XENT-F

View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005693/en/

CONTACT: Intersect ENT

Jeri Hilleman, 650-641-2105

ir@intersectENT.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Intersect ENT

Copyright Business Wire 2018.

PUB: 11/07/2018 04:05 PM/DISC: 11/07/2018 04:05 PM

http://www.businesswire.com/news/home/20181107005693/en

AP RADIO
Update hourly